Evaluation of Immune Checkpoint Inhibitors' Efficacy for the Treatment of Locally Metastatic Melanoma in a Country with Limited Drug Supply
Background: Immune checkpoint inhibitors have demonstrated remarkable efficacy in treating melanoma in various regions. However, in countries with a non-continuous drug supply, ensuring consistent access to pembrolizumab becomes a critical concern. Objective: This study was to evaluate the efficacy of Pembrolizumab in...